bpc 157 bioavailability oral vs subcutaneous injection use BPC-157 Injection: Benefits, & Recovery The Hidden Risks of BPC‑157: – Oral vs Injectable BPC-157: Differences,

doi: 10.1042/bj2450439

Research suggests the opposite

Note that the numbers in parentheses (1, 2, etc.) are clickable links to these studies

The report highlights early metabolic studies, selected clinical trials, and certain double-blind placebo-controlled investigations that examined markers such as: blood sugar regulation insulin sensitivity cholesterol levels impaired glucose tolerance adipose tissue activity fat release and lipolytic activity While these studies generated interest in AOD-9604 as a potential anti-obesity drug candidate , the report stresses that no authority recognizes it as an active treatment for obesity, weight loss, or human use and emphasizes that it remains designated strictly for research use